WEST PHARMACEUTICAL SERVICES (WST)
US9553061055 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 568.70M | 593.40M | 585.90M | 661.80M | 346.20M | |||
| Depreciation Amortization | 141.30M | 137.30M | 120.60M | 122.30M | 109.10M | |||
| Income Taxes - Deferred | N/A | 37.50M | -30.80M | -42.90M | -5.80M | |||
| Change In Working Capital | -8.20M | -20.40M | -11.50M | -193.80M | -10.30M | |||
| Interest Paid | N/A | 6.00M | 6.60M | 8.00M | 8.10M | |||
| Taxes Paid | N/A | 90.80M | 109.70M | 171.80M | 48.40M | |||
| Other non cash items | 17.30M | 28.70M | 59.80M | 36.60M | 33.30M | |||
| OPERATING CASH FLOW | 756.60M | 776.50M | 724.00M | 584.00M | 472.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -370.50M | -362.00M | -284.60M | -253.40M | -174.40M | |||
| Other Investing Activity | N/A | -6.70M | -3.60M | 300.00K | -5.10M | |||
| INVESTING CASH FLOW | -377.20M | -368.70M | -288.20M | -253.10M | -179.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.30M | -2.30M | -44.30M | -2.20M | -2.30M | |||
| Stock Issued/Repurchased | -599.50M | -400.20M | -194.00M | -114.80M | -86.70M | |||
| Dividend Paid | -57.60M | -57.00M | -54.10M | -51.10M | -48.10M | |||
| Other Financing Activity | -200.00K | -100.00K | -1.20M | 0.00 | N/A | |||
| FINANCING CASH FLOW | -659.60M | -459.60M | -293.60M | -168.10M | -137.10M | |||
| Exchange Rate Effect | -4.30M | 11.40M | -10.50M | -15.70M | 20.50M | |||
| CHANGE IN CASH | -284.50M | -40.40M | 131.70M | 147.10M | 176.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 756.60M | 776.50M | 724.00M | 584.00M | 472.50M | |||
| Capital Expenditure | -370.50M | -362.00M | -284.60M | -253.40M | -174.40M | |||
| FREE CASH FLOW | 386.10M | 414.50M | 439.40M | 330.60M | 298.10M | |||
All data in USD